Biology Reference
In-Depth Information
48. Villares GJ, Zigler M, Wang H, Melnikova VO, Wu H, Friedman R et al (2008) Targeting
melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-
activated receptor-1 small interfering RNA. Cancer Res 68(21):9078-9086
49. Landen CN Jr, Chavez-Reyes A, Bucana C, Schmandt R, Deavers MT, Lopez-Berestein G
et al (2005) Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfer-
ing RNA delivery. Cancer Res 65(15):6910-6918
50. Anderson DG, Akinc A, Hossain N, Langer R (2005) Structure/property studies of polymeric
gene delivery using a library of poly(beta-amino esters). Mol Ther 11(3):426-434
51. Akinc A, Zumbuehl A, Goldberg M, Leshchiner ES, Busini V, Hossain N et al (2008) A com-
binatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat Biotechnol
26(5):561-569
52. Leng Q, Goldgeier L, Zhu J, Cambell P, Ambulos N, Mixson AJ (2007) Histidine-lysine pep-
tides as carriers of nucleic acids. Drug News Perspect 20(2):77-86
53. Leng Q, Scaria P, Lu P, Woodle MC, Mixson AJ (2008) Systemic delivery of HK Raf-1 siRNA
polyplexes inhibits MDA-MB-435 xenografts. Cancer Gene Ther 15(8):485-495
54. Yan Z, Zou H, Tian F, Grandis JR, Mixson AJ, Lu PY et al (2008) Human rhomboid family-1
gene silencing causes apoptosis or autophagy to epithelial cancer cells and inhibits xenograft
tumor growth. Mol Cancer Ther 7(6):1355-1364
55. Honma K, Iwao-Koizumi K, Takeshita F, Yamamoto Y, Yoshida T, Nishio K et al (2008) RPN2
gene confers docetaxel resistance in breast cancer. Nat Med 14(9):939-948
56. Fujii T, Saito M, Iwasaki E, Ochiya T, Takei Y, Hayashi S et al (2006) Intratumor injection of
small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the
growth of cervical cancer. Int J Oncol 29(3):541-548
57. Mu P, Nagahara S, Makita N, Tarumi Y, Kadomatsu K, Takei Y (2009) Systemic delivery of
siRNA specific to tumor mediated by atelocollagen: combined therapy using siRNA targeting
Bcl-xL and cisplatin against prostate cancer. Int J Cancer 125(12):2978-2990
58. Wolfrum C, Shi S, Jayaprakash KN, Jayaraman M, Wang G, Pandey RK et al (2007)
Mechanisms and optimization of in vivo delivery of lipophilic siRNAs. Nat Biotechnol
25(10):1149-1157
59. Nishina K, Unno T, Uno Y, Kubodera T, Kanouchi T, Mizusawa H et al (2008) Efficient in vivo
delivery of siRNA to the liver by conjugation of alpha-tocopherol. Mol Ther 16(4):734-740
60. Lorenz C, Hadwiger P, John M, Vornlocher HP, Unverzagt C (2004) Steroid and lipid conju-
gates of siRNAs to enhance cellular uptake and gene silencing in liver cells. Bioorg Med Chem
Lett 14(19):4975-4977
61. McNamara JO 2nd, Andrechek ER, Wang Y, Viles KD, Rempel RE, Gilboa E et al (2006) Cell
type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nat Biotechnol
24(8):1005-1015
62. Rozema DB, Lewis DL, Wakefield DH, Wong SC, Klein JJ, Roesch PL et al (2007) Dynamic
PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes. Proc Natl Acad Sci
USA 104(32):12982-12987
63. Schiffelers RM, Ansari A, Xu J, Zhou Q, Tang Q, Storm G et al (2004) Cancer siRNA therapy
by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic
Acids Res 32(19):e149
64. Hu-Lieskovan S, Heidel JD, Bartlett DW, Davis ME, Triche TJ (2005) Sequence-specific
knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits
tumor growth in a murine model of metastatic Ewing's sarcoma. Cancer Res
65(19):8984-8992
65. Davis ME (2009) The fi rst targeted delivery of siRNA in humans via a self-assembling, cyclo-
dextrin polymer-based nanoparticle: from concept to clinic. Mol Pharm 6(3):659-668
66. Andrabi SM (2007) Mammalian sperm chromatin structure and assessment of DNA fragmen-
tation. J Assist Reprod Genet 24(12):561-569
67. Song E, Zhu P, Lee SK, Chowdhury D, Kussman S, Dykxhoorn DM et al (2005) Antibody
mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat Biotechnol
23(6):709-717
Search WWH ::
Custom Search